Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study
Hematological Oncology - United Kingdom
doi 10.1002/hon.120_2631
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley